Aladdin Scientific
Quisovalimab (anti-TNFSF14) (C007B-554008)
Quisovalimab (anti-TNFSF14) is a human monoclonal antibody against LIGHT, a tumor necrosis factor (TNF)-related cytokine (TNFSF14) that plays an important role in acute respiratory distress syndrome (ARDS) and cytokine release syndrome (CRS)
Description
Quisovalimab (anti-TNFSF14) is a human monoclonal antibody against LIGHT, a tumor necrosis factor (TNF)-related cytokine (TNFSF14) that plays an important role in acute respiratory distress syndrome (ARDS) and cytokine release syndrome (CRS) COVID-19. Quisovalimab (anti-TNFSF14) can be used in COVID-19 acute respiratory distress syndrome and other studies.
Specification: Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/AB191918-SCI_a86a2cbc3dc0ab1e2e9d44f8b3d5c75e.pdf
Specifications
- UPC:
- 51111731
- Condition:
- New
- Weight:
- 0.07 Ounces
- HazmatClass:
- No
- Quantity:
- 1
- Unit of Measurement:
- EA
- WeightUOM:
- LB
- MPN:
- Ab191918-1mg
- CAS:
- 2427667-03-4
- Product Size:
- 1mg
-
Fast shipping — 3-day lead time
-
Guaranteed quality & reliable delivery
-
Shipping Lead-Time: 5-10 days
